Bon Natural Life
2 hedge funds and large institutions have $18K invested in Bon Natural Life in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
0.22% less ownership
Funds ownership: 0.32% → 0.1% (-0.22%)
33% less funds holding
Funds holding: 3 → 2 (-1)
89% less capital inflows, than outflows
Capital inflows: $6.46K | Capital outflows: $58K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$6.46K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$58K |
BON Hedge Fund Activity: Q3 2022 in Review
2 of the 5,832 institutional investors tracked by Wall St. Rank reported a position in Bon Natural Life (BON) for Q3 2022, worth a combined $18K — down 75% from $72K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BON and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $6.46K. The largest seller was Citadel Advisors, exiting entirely with an estimated $58K sold.
- 2 institutional investors held Bon Natural Life (BON) as of Q3 2022, down from 3 in Q2 2022.
- Funds reported $18K of Bon Natural Life stock for Q3 2022, down 75% quarter-over-quarter.
- 0 funds opened new Bon Natural Life positions in Q3 2022 and 1 closed out, a net change of -1 holder.
- The largest Bon Natural Life buyer in Q3 2022 was UBS Group, an estimated $6.46K added.
- The largest Bon Natural Life seller in Q3 2022 was Citadel Advisors, an estimated $58K sold.
Based on aggregated 13F filings for Q3 2022.